白细胞介素17与牙周炎相关性的研究进展

摘要/Abstract

摘要： 牙周炎是由牙周致病菌所致的牙周组织慢性炎症性，破坏性疾病。IL-17是一种主要由T细胞产生的促炎因子，参与牙周炎的发生、发展，并可能与牙周炎严重性相关。本文就IL-17参与牙周炎症免疫应答反应及牙槽骨吸收的机制做一综述，旨在阐明IL-17参与牙周疾病的研究现状。

关键词: IL-17, 牙周炎, 牙槽骨吸收

Abstract: Periodontitis is a chronic inflammatory and destruction disease caused by periodontal pathogens in the surrounding periodontal tissues.The pro-inflammatory cytokine IL-17, mainly produced by T cells ,which involved in the occurrence and development of periodontitis and this may be associated with disease severity.In this artical, we will review the inflammatory immune response and the mechanisms of alveolar bone absorption induced by IL-17 to illustrate the current research status of IL - 17 in periodontal disease.

Key words: IL-17, Periodontitis, Alveolar bone absorption

中图分类号:

R780.2

刘引高涵于海蛟周岳申玉芹林崇韬. 白细胞介素17与牙周炎相关性的研究进展[J]. 口腔医学, 2015, 35(6): 487-489.

参考文献

[1] Chang S H, Dong C. Signaling of interleukin-17 family cytokines in immunity and in-flammation[J]. Cellular signalling, 2011, 23(7): 1069-1075.
[2] Gu C, Wu L, Li X. IL-17 family: Cytokines, receptors and signaling[J]. Cytokine, 2013,64(2):477-485.
[3] Reynolds J M, Angkasekwinai P, Dong C. IL-17 family member cytokines: regulationand function in innate immunity[J]. Cytokine & growth factor reviews, 2010, 21(6): 413-423.
[4] Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-pr-oducingcells[J]. Nature Reviews Immunology, 2006, 6(4): 329-334.
[5] Song X, Qian Y. IL-17 family cytokines mediated signaling in the pathogenesis of in-flammatory diseases[J]. Cellular signalling, 2013, 25(12): 2335-2347.
[6] Rouvier E, Luciani M F, Mattei M G, et al. CTLA-8, cloned from an activated T cell,bearingAU-rich messenger RNA instability sequences, and homologous to a herpesvirus sa-imiri gene[J]. The Journal of Immunology, 1993, 150(12): 5445-5456.
[7]Yao Z, Fanslow W C, Seldin M F, et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor[J]. Journal of immunology (Baltimore, Md.: 1950), 2011, 187(9): 4392-4402.
[8] Korn T, Bettelli E, Oukka M, et al. IL-17 and Th17 Cells[J]. Annual review of immunology, 2009, 27: 485-517.
[9] Yao Z, Painter S L, Fanslow W C, et al. Human IL-17: a novel cytokine derived from T cells[J]. The Journal of Immunology, 1995, 155(12): 5483-5486.
[10] Iwakura Y, Ishigame H, Saijo S, et al. Functional specialization of interleukin-17 family members[J]. Immunity, 2011, 34(2): 149-162.
[11] Song X, Qian Y. The activation and regulation of IL-17 receptor mediated signaling[J]. Cytokine, 2013, 62(2): 175-182.
[12] Shen F, Gaffen S L. Structure–function relationships in the IL-17 receptor: implications for signal transduction and therapy[J]. Cytokine, 2008, 41(2): 92-104.
[13] Park Y D, Kim Y S, Jung Y M, et al. Porphyromonas gingivalis lipopolysaccharid-e regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal li- gament cells[J]. Cytokine, 2012, 60(1): 284-293.
[14]. Cardoso C R, Garlet G P, Crippa G E, et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease[J]. Oral microbiology and immunology, 2009, 24(1): 1-6.
[15] Lester S R, Bain J L, Johnson R B, et al. Gingival concentrations of interleukin-23 and-17 at healthy sites and at sites of clinical attachment loss[J]. Journal of periodontology, 2007, 78(8): 1545-1550.
[16] Adibrad M, Deyhimi P, Ganjalikhani Hakemi M, et al. Signs of the presence of Th17 cells in chronic periodontal disease[J]. Journal of periodontal research, 2012, 47(4): 525-531.
[17] Allam J P, Duan Y, Heinemann F, et al. IL‐23‐producing CD68+ macrophage‐like cells predominate within an IL‐17‐polarized infiltrate in chronic periodontitis lesions[J]. Journal of clinical periodontology, 2011, 38(10): 879-886.
[18] Shaker O G, Ghallab N A. IL-17 and IL-11 GCF levels in aggressive and chronic periodontitis patients: relation to PCR bacterial detection[J]. Mediators of inflammation, 2012, 2012.
[19] Duarte P M, da Rocha M, Sampaio E, et al. Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: a pilot study[J]. Journal of periodontology, 2010, 81(7): 1056-1063.
[20] Dutzan N, Vernal R, Vaque J P, et al. Interleukin-21 expression and its association with proinflammatory cytokines in untreated chronic periodontitis patients[J]. Journal of periodontology, 2012, 83(7): 948-954.
[21] Dutzan N, Gamonal J, Silva A, et al. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-κ B ligand, interleukin (IL)-17, IL-10 and transforming growth factor-β during the progression of chronic periodontitis[J]. Journal of clinical periodontology, 2009, 36(5): 396-403.
[22] Zhao L, Zhou Y, Xu Y, et al. Effect of non-surgical periodontal therapy on the levels of Th17/Th1/Th2 cytokines and their transcription factors in Chinese chronic periodontitis patients[J]. Journal of clinical periodontology, 2011, 38(6): 509-516.
[23] Cheng W C, Hughes F J, Taams L S. The presence, function and regulation of IL-17 and Th17 cells in periodontitis[J]. Journal of clinical periodontology, 2014, 41(6): 541-549.
[24] Guerrini M M, Takayanagi H. The immune system, bone and RANKL[J]. Archives of biochemistry and biophysics, 2014, 561: 118-123.
[25] Ohyama H, Kato-Kogoe N, Kuhara A, et al. The involvement of IL-23 and the Th17 pathway in periodontitis[J]. Journal of Dental Research, 2009, 88(7): 633-638.
[26] Kim Y G, Park J W, Lee J M, et al. IL-17 inhibits osteoblast differentiation and bone regeneration in rat[J]. Archives of Oral Biology, 2014.
[27] 闫秀娟, 吴晓光, 郗红, 等. 二膦酸盐干预牙槽骨吸收及其机制[J]. 国际口腔医学杂志 ISTIC, 2014 (4).
[28] L?nnberg A S, Zachariae C, Skov L. Targeting of interleukin-17 in the treatment of psoriasis[J]. Clinical, cosmetic and investigational dermatology, 2014, 7: 251.
[29] Patel D D, Lee D M, Kolbinger F, et al. Effect of IL-17A blockade with secukinumab in autoimmune diseases[J]. Annals of the rheumatic diseases, 2012: annrheumdis-2012-202371.